Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

被引：1
|
作者：
Scaramellini, Natalia [1 ]
Arighi, Carola [1 ]
Marcon, Alessia [1 ]
Consonni, Dario [2 ]
Cassinerio, Elena [1 ]
Graziadei, Giovanna [1 ]
Cappellini, Maria Domenica [1 ]
Motta, Irene [3 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gen Med Unit, Rare Dis Ctr, Milan, Italy
[2] Fdn IRCCS Osped Maggiore Policlin Milan, Epidemiol, Milan, Italy
[3] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130237
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3542
引用
收藏
页数：4
相关论文
共 50 条
  • [1] A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L
    Scaramellini, Natalia
    Consonni, Dario
    Cassinerio, Elena
    Arighi, Carola
    Marcon, Alessia
    Graziadei, Giovanna
    Cappellini, Maria Domenica
    Motta, Irene
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) : E230 - E232
  • [2] β-Thalassemia: evolving treatment options beyond transfusion and iron chelation
    Langer, Arielle L.
    Esrick, Erica B.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 600 - 606
  • [3] IRON CHELATION IN TRANSFUSION-DEPENDENT THALASSEMIA WITH CHRONIC HEPATITIS
    DEVIRGILIIS, S
    COSSU, P
    SANNA, G
    FRAU, F
    LOI, E
    LOBRANO, R
    NUCARO, A
    TOCCAFONDI, C
    CORNACCHIA, G
    LOI, A
    CAO, A
    [J]. ACTA HAEMATOLOGICA, 1982, 67 (01) : 49 - 56
  • [4] Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
    Irene Motta
    Rayan Bou-Fakhredin
    Ali T. Taher
    Maria Domenica Cappellini
    [J]. Drugs, 2020, 80 : 1053 - 1063
  • [5] Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
    Motta, Irene
    Bou-Fakhredin, Rayan
    Taher, Ali T.
    Cappellini, Maria Domenica
    [J]. DRUGS, 2020, 80 (11) : 1053 - 1063
  • [6] Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
    Bou-Fakhredin, Rayan
    Bazarbachi, Abdul-Hamid
    Chaya, Bachar
    Sleiman, Joseph
    Cappellini, Maria Domenica
    Taher, Ali T.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [7] Iron Chelation in Patients with Transfusion Dependent Thalassemia: An Insight on Response to Deferasirox
    Shaikh, Muhammad Shariq
    Adil, Salman Naseem
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2015, 25 (07): : 553 - 554
  • [8] CARDIAC AND HEPATIC IRON ASSESSMENT OF YOUNG ADULTS WITH TRANSFUSION DEPENDENT THALASSEMIA: TIME TO THINK BEYOND FERRITIN
    Mishra, K.
    Kashyap, S.
    Khadwal, A.
    Jandial, A.
    Lad, D.
    Prakash, G.
    Das, R.
    Varma, N.
    Malhotra, P.
    Varma, S.
    [J]. HAEMATOLOGICA, 2017, 102 : 869 - 869
  • [9] Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation
    Chauhan, Waseem
    Shoaib, Shoaib
    Fatma, Rafat
    Zaka-ur-Rab, Zeeba
    Afzal, Mohammad
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3610 - 3626
  • [10] Iron Chelation Therapy in Transfusion Dependent Patients with Thalassemia and Minimal Liver Iron Load
    Kattamis, Antonios
    Stokidis, Konstantinos
    Petropoulou, Tbeoni
    Kyriacopoulou, Dimitra
    Delaporta, Polyxeni
    Papassptiriou, Ioannis
    Ladis, Vassilis
    [J]. BLOOD, 2010, 116 (21) : 1733 - 1733
12345